Department of Cardiology, Ospedale di Cremona, Cremona, Italy.
Department of Cardiology, GVM Care & Research Maria Cecilia Hospital, Cotignola (RA), Italy.
PLoS One. 2021 Jan 22;16(1):e0245565. doi: 10.1371/journal.pone.0245565. eCollection 2021.
Several studies reported a high incidence of pulmonary embolism (PE) among patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but detailed data about clinical characteristics, risk factors of these patients and prognostic role of PE are still lacking. We aim to evaluate the occurrence of pulmonary embolism among patients with SARS-CoV-2 infection, and to describe their risk factors, clinical characteristics, and in-hospital clinical outcomes.
This is a multicenter Italian study including 333 consecutive SARS-CoV-2 patients admitted to seven hospitals from February 22 to May 15, 2020. All the patients underwent computed tomography pulmonary angiography (CTPA) for PE detection. In particular, CTPA was performed in case of inadequate response to high-flow oxygen therapy (Fi02≥0.4 to maintain Sp02≥92%), elevated D-dimer (>0.5μg/mL), or echocardiographic signs of right ventricular dysfunction. Clinical, laboratory and radiological data were also analyzed.
Among 333 patients with laboratory confirmed SARS-CoV-2 pneumonia and undergoing CTPA, PE was detected in 109 (33%) cases. At CTPA, subsegmental, segmental, lobar and central thrombi were detected in 31 (29%), 50 (46%), 20 (18%) and 8 (7%) cases, respectively. In-hospital death occurred in 29 (27%) patients in the PE-group and in 47 (21%) patients in the non-PE group (p = 0.25). Patients in PE-group had a low rate of traditional risk factors and deep vein thrombosis was detected in 29% of patients undergoing compression ultrasonography. In 71% of cases with documented PE, the thrombotic lesions were located in the correspondence of parenchymal consolidation areas.
Despite a low rate of risk factors for venous thromboembolism, PE is present in about 1 out 3 patients with SARS-CoV-2 pneumonia undergoing CTPA for inadequate response to oxygen therapy, elevated D-dimer level, or echocardiographic signs of right ventricular dysfunction. In most of the cases, the thromboses were located distally in the pulmonary tree and were mainly confined within pneumonia areas.
几项研究报告称,严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染患者中肺栓塞(PE)的发生率较高,但关于这些患者的临床特征、危险因素和 PE 的预后作用的详细数据仍缺乏。我们旨在评估 SARS-CoV-2 感染患者中肺栓塞的发生情况,并描述其危险因素、临床特征和住院临床结局。
这是一项多中心意大利研究,纳入了 2020 年 2 月 22 日至 5 月 15 日期间来自七家医院的 333 例连续 SARS-CoV-2 患者。所有患者均行 CT 肺动脉造影(CTPA)以检测 PE。特别是在高流量氧疗(Fi02≥0.4 以维持 Sp02≥92%)反应不佳、D-二聚体升高(>0.5μg/mL)或超声心动图右心室功能障碍迹象时,进行 CTPA。还分析了临床、实验室和影像学数据。
在 333 例经实验室证实的 SARS-CoV-2 肺炎且行 CTPA 的患者中,109 例(33%)检测到 PE。在 CTPA 中,分别在 31 例(29%)、50 例(46%)、20 例(18%)和 8 例(7%)患者中检测到亚段、节段、肺叶和中央血栓。PE 组住院期间死亡 29 例(27%),非 PE 组 47 例(21%)(p=0.25)。PE 组患者传统危险因素发生率较低,接受压缩超声检查的患者中有 29%发现深静脉血栓形成。在有记录的 PE 病例中,71%的血栓病变位于实质实变区域的对应部位。
尽管静脉血栓栓塞的危险因素发生率较低,但在因氧疗反应不佳、D-二聚体水平升高或超声心动图右心室功能障碍而行 CTPA 的 SARS-CoV-2 肺炎患者中,约有 1/3 存在 PE。在大多数情况下,血栓位于肺树的远端,主要局限于肺炎区域内。